Treatment of pulmonary embolism

1. Thrombolysis. The indication for treatment is patients with massive pulmonary embolism on the patient side. The thrombolytic time is within 14 days. The complications of treatment include bleeding. The absolute contraindications for thrombolytic therapy include: Active internal bleeding, recent spontaneous intracranial bleeding, relative contraindications include major surgery, childbirth, organ biopsy, ischemic stroke within two months of vascular puncture without compression, gastrointestinal bleeding within ten days, severe trauma within fifteen days, neurosurgery or ophthalmic surgery within one month, uncontrolled hypertension, recent cardiopulmonary resuscitation, low platelets, pregnancy, infectious endocarditis, etc. 2. Use urokinase streptokinase for thrombolysis, but do not emphasize the simultaneous use of heparin therapy, but heparin therapy must be used simultaneously when using RTPA for thrombolysis. 3. Before using heparin low molecular weight glycosides, coagulation indicators should be determined, as well as blood routine. When using warfarin, it is also necessary to regularly monitor the international standardized ratio. Thrombolysis can be considered after pulmonary embolism is highly suspected and other diagnoses are ruled out.